Literature DB >> 7068681

The H1 histones and their interphase phosphorylated states in differentiated and undifferentiated cell lines derived from murine teratocarcinomas.

R W Lennox, R G Oshima, L H Cohen.   

Abstract

The histone H1 fraction from the murine embryonal carcinoma cell line F9 can be resolved by two-dimensional gel electrophoresis into at least 15 components. Ten of these components incorporate 32P from administered orthophosphate. The digestion of 3H- and 32P-labeled samples with alkaline phosphatase indicates that this cell line has at least five H1 subtypes, three of which have not been observed in the mouse before. Every subtype is phosphorylated to some extent. There are, however, striking differences among them in the degree of phosphorylation in interphase, both in the proportion of molecules present as phosphorylated forms and in the numbers of phosphate groups per molecule. Phosphorylations of two types are discernible; most phosphorylations do not significantly affect the mobility of the protein in sodium dodecyl sulfate-containing gels but one does, probably reflecting a phosphorylation-induced alteration in protein conformation. Four subtypes undergo only the first type of phosphorylation; the other subtype undergoes both types of phosphorylation. The same 5 subtypes are also present in two other independently derived embryonal carcinoma cell lines. In contrast, two differentiated (endoderm-like) cell lines derived from teratocarcinomas lack H1b, and one also lacks H1d. Our results are consistent with the view that the H1 subtypes differ from each other functionally. They also show that neither H1b nor H1d is essential for cell division.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  The preferential binding of histone H1 to DNA scaffold-associated regions is determined by its C-terminal domain.

Authors:  Alicia Roque; Mary Orrego; Imma Ponte; Pedro Suau
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

Review 2.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

3.  Separation of rat tissue histone H1 subtypes by reverse-phase h.p.l.c. Identification and assignment to a standard H1 nomenclature.

Authors:  H Lindner; W Helliger; B Puschendorf
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

4.  Normal spermatogenesis in mice lacking the testis-specific linker histone H1t.

Authors:  Q Lin; A Sirotkin; A I Skoultchi
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  The primary structure of the major isoform (H1.1) of histone H1 from the nematode Caenorhabditis elegans.

Authors:  J R Vanfleteren; S M Van Bun; J J Van Beeumen
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

6.  Rapid induction of polyadenylated H1 histone mRNAs in mouse erythroleukemia cells is regulated by c-myc.

Authors:  G H Cheng; A I Skoultchi
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

7.  Isolation and characterization of two replication-dependent mouse H1 histone genes.

Authors:  Y Dong; A M Sirotkin; Y S Yang; D T Brown; D B Sittman; A I Skoultchi
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

8.  In vivo and in vitro methylation of lysine residues of Euglena gracilis histone H1.

Authors:  S Syed; R Rajpurohit; S Kim; W K Paik
Journal:  J Protein Chem       Date:  1992-06

9.  Alteration in proportions of histone H1 variants during the differentiation of murine erythroleukaemic cells.

Authors:  W Helliger; H Lindner; O Grübl-Knosp; B Puschendorf
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  Histone H1 subtypes differentially modulate chromatin condensation without preventing ATP-dependent remodeling by SWI/SNF or NURF.

Authors:  Jaime Clausell; Nicole Happel; Tracy K Hale; Detlef Doenecke; Miguel Beato
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.